five

Dataset from Partially-blind Immunogenicity and Safety Study of GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults.

收藏
NIAID Data Ecosystem2026-05-02 收录
下载链接:
https://doi.org/10.25934/00001501
下载链接
链接失效反馈
官方服务:
资源简介:
This study is designed to assess the safety and immunogenicity of a GSK Biologicals' investigational vaccine GSK2321138A in adults 18 years old and older. This study is also designed to assess the lot-to-lot consistency of vaccine GSK2321138A. The blinding will be double blind for all groups except for the GSK2604409A Group which will be open.
创建时间:
2024-11-27
二维码
社区交流群
二维码
科研交流群
商业服务